For the quarter ending 2025-09-30, NDRA has $1,964,108 in assets. $1,792,728 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 794,036 | - | ||
| Prepaid expenses | 254,673 | 44,310 | ||
| Cash | - | 1,808,574 | ||
| Total current assets | 1,048,709 | 1,852,884 | ||
| Other assets | - | 5,986 | ||
| Fixed assets, net | 52,633 | 63,419 | ||
| Right of use assets | 491,363 | 519,966 | ||
| Prepaid expenses, long term | 365,417 | 365,417 | ||
| Other assets | 5,986 | - | ||
| Total assets | 1,964,108 | 2,807,672 | ||
| Accounts payable and accrued liabilities | 671,516 | 448,419 | ||
| Lease liabilities, current portion | 128,791 | 128,218 | ||
| Total current liabilities | 800,307 | 576,637 | ||
| Warrant liability | - | 328,610 | ||
| Lease liabilities | 396,537 | - | ||
| Preferred stock, value-Series CConvertible Preferred Stock | - | 0 | ||
| Lease liabilities | - | 429,274 | ||
| Warrant liability | 595,884 | - | ||
| Preferred stock, value-Series BConvertible Preferred Stock | - | 0 | ||
| Total long term debt | 992,421 | 757,884 | ||
| Preferred stock, value-Series AConvertible Preferred Stock | - | 0 | ||
| Total liabilities | 1,792,728 | 1,334,521 | ||
| Common stock, 0.0001 par value 20,000,000 shares authorized 786,902 and 536,908 shares issued and outstanding, respectively | 77 | 74 | ||
| Additional paid in capital | 107,467,603 | 107,173,418 | ||
| Stock payable | - | 0 | ||
| Accumulated deficit | -107,296,300 | -105,700,341 | ||
| Total stockholders equity | 171,380 | 1,473,151 | ||
| Total liabilities and stockholders equity | 1,964,108 | 2,807,672 | ||
ENDRA Life Sciences Inc. (NDRA)
ENDRA Life Sciences Inc. (NDRA)